1.18 -0.05 (-4.07%)
INO
Stock Details
Last Trade:1.18 Change:-0.05 (-4.07%) Prev Close:1.23 Open: 1.23 Days Range:1.10 – 1.25 52 Week Range: 0.18 - 3.40 Volume:400270 P/E: N/AEPS:-0.39
View AllRecent Alerts 02/10/10
Recent Alert on 02/08/10 at 7:52am
Inovio Biomedical (INO) Announces Interim Safety and Immunogenicity Data for VGX-3100
Inovio Biomedical (INO) Announces Interim Safety and Immunogenicity Data for VGX-3100
Inovio Biomedical Corporation (AMEX: INO) announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human... Read More
Recent Alert on 02/08/10 at 7:52am
Inovio Biomedical (INO) Announces Interim Safety and Immunogenicity Data for VGX-3100
Inovio Biomedical (INO) Announces Interim Safety and Immunogenicity Data for VGX-3100
Recent Alert on 01/11/10 at 10:28am
Morning Movers 01/11: PEIX, EPCT, MMR, TUES, KTII Higher; CYCC, LUNA, IOC, ASBC, HOGS Lower
Morning Movers 01/11: PEIX, EPCT, MMR, TUES, KTII Higher; CYCC, LUNA, IOC, ASBC, HOGS Lower
Recent Alert on 11/20/09 at 12:16pm
Unusual 11 Mid-Day Movers 11/20: GGR, TTIL, INO, NLST Higher; EFUT, HAWK, ADCT, DHI Lower
Unusual 11 Mid-Day Movers 11/20: GGR, TTIL, INO, NLST Higher; EFUT, HAWK, ADCT, DHI Lower
View AllRecent Press Releases
Press Release on 02/08/10 at 7:00am
Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial
Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial
View AllRecent SEC Filings
No Recent SEC Filings Available